LIBROS
Henderson JE, Goldzman D, eds. The osteoporosis primer. New York: Cambridge University Press, 2000.
McLlwain H, Bruce DF, eds. Super calcium counter: The essential guide to preventing osteoporosis and building strong bones. New York: Kensington, 2000.
Obrant K, ed. Management of fractures in severely osteoporotic bone: Orthopedic and pharmacologic strategies. New York: Springer-Verlag, 2000.
Fordham JN, ed. Manual of bone densitometry measurements. An aid to the interpretation of bone densitometry measurements in a clinical setting. Heidelberg: Springer-Verlag, 2000.
Kato J, Minaguchi H, Nishino Y, eds. Hormone replacement therapy and osteoporosis. New York: Springer-Verlag, 2000.
Cox M, Mays S, eds. Human osteology in archeology and forensic medicine. London: Greenwich Medical Media, 2000.
Giugliano D, Sedge M, Sepe J, eds. The Mediterranean diet: origins and myths. Nápoles: Idelson-Gnocchi, 2000.
Crepaldi G, Maggi S, Giannini S, Sartori L, eds. L'osteoporosi nella pratica clinica. Roma: CIC, 2001.
Isaia G, ed. Le malattie del metabolismo mineral. Guida pratica alla gestione operativa. Roma: Centro Scientifico Editore, 2001.
NUMEROS MONOGRAFICOS
Jee WSS, Yao W, eds. Animal models of bone diseases. J Musculoeskel Neuron Interact 2001; 1: 183-289.
NUESTROS AUTORES
Zanchetta JR, Bogado CE. Raloxifene reverses bone loss in postmenopausal women with mild asymptomatic primary hyperparathyroidism. J Bone Miner Res 2001; 16: 189-190.
Becerra J, Andrades JA, Santamaría JA, Cienfuentes M, Guerado E. Regeneración ósea, terapia celular e ingeniería tisular. Med Clin (Barc) 2001; 116: 23-24.
Díaz Curiel M, García JJ, Carrasco JL, Honorato J, Pérez Cano R, Rapado A, Álvarez C. Prevalencia de osteoporosis determinada por densitometría en la población femenina española. Med Clinica (Barc) 2001; 116: 86-88.
Montalbán J, Rico H, Cortés J, Pedrera JD. Masa ósea cortical y factores de riesgo para osteoporosis en mujeres postmenopáusicas en nuestro medio. Rev Clin Esp 2001; 201: 16-20.
Fradinger EE, Zanchetta JR. Vitamin D and bone mineral density in ambulatory women living in Buenos Aires, Argentina. Osteoporosis Int 2001; 12: 24-27.
Mora C, Navarro JF. Enfermedad ósea adinámica e hipoparatiroidismo relativo en la uremia. Nefrología 2001; 21: 26-40.
Álvarez J, Balbín M, Fernández M, López JM. Collagen metabolism is markedly altered in the hypertrophic cartilage of growth plates from rats with growth impairement secodary to chronic renal failure. J Bone Miner Res 2001; 16: 511-524.
Se ruega a los autores enviar una copia del trabajo para incluir su cita en esta Sección.
REVISIONES
Jee WSS, Yao W. Animal models of ostopenia and osteoporosis. J Musculoeskel Neuron Interact 2001; 1: 193-208.
Heaney RP, Abrams S, Swsmit-Hughes B, et al. Peak bone mass. Osteoporosis Int 2000; 11: 985-1.009.
Clemons M, Goss P. Estrogen and the risk of breast cancer. New Eng J Med 2001; 344: 276-285.
Kühne CA, Heufelder AE, Hofbauer LC. Bone and mineral metabolism in human immunodeficiency virus infection. J Bone Miner Res 2001; 16: 2-9.
Tomlinson JW, Bujalska I, Stewart PM, Cooper MS. The role of 11B-hydroxysteroid dehydrogenase in central obesity and osteoporosis. Endocrine Res 2001; 27: 711-722.
Jee WS. Anabolic agents and osteoporosis: Quo Vadis? J Musculoeskel Neuron Interact 2000; 1: 107-111.
Talmage RV, Lester GE, Hirsch PF. Parathyroid hormone and plasma calcium control: an editorial. J Musculoeskel Neuron Interact 2000; 1: 121-126.
Nelson DA, Bouxein ML. Exercise maintains bone mass, but Do people maintain exercise? J Bone Miner Res 2001; 16: 202-205.
Byers RJ, Braidman IP. Osteoporosis in men: a cellular endocrine perspective of an increasing common clinical problem. J Endocrinol 2001; 168: 353-362.
Carling T. Molecular pathology of parathyroid tumors. Trends Endocrinol Metab 2001; 12: 53-58.
Pearle MS. Prevention of nephrolithiasis. Curr Opin Nephrol Hypertens 2001; 10: 203-209.
Njeh CF, Fuerst T, Diessel E, Genant HG. Is quantitative ultrasound dependent on bone structure? A reflexion. Osteoporosis Int 2001; 12: 1-15.
Forwood MR. Mechanical effects of the skeleton: are there clinical implications? Osteoporosis Int 2001; 12: 77-83.
Osteoporosis: prevention, diagnosis and therapy. JAMA 2001; 785-795.
Francis RM, Baillie SO, Chunck AJ, et al. Management of osteoporosis in patients with hip fractures. Q J Med 2000; 93: 501-506.
Hobson EE, Ralston SH. Role of genetic factors in the physiology and management of osteoporosis. Clin Endocrinol 2001; 54: 1-10.
Compston JE. Sex steroid and bone. Physiol Rev 2001; 81: 419-448.
Erben RG. Skeletal effects of androgen withdrawal. J Musculoeskel Neuron Interact 2001; 1: 225-234.
Robling AG, Burr DB, Turner CH. Skeletal loading in animals. J Musculoeskel Neuron Interact 2001; 1: 249-262.
Fleish H. Can biphosphonates be given to patients with fractures? J Bone Miner Res 2001; 16: 437-440.
OTROS ARTICULOS DE INTERÉS
Fox KM, Cummings SR, Williams E, et al. Femoral neck and intertrochanteric fractures have different risk factors: a prospective study. Osteoporosis Int 2000; 11: 1.018-1.023.
Seeman E, Duan Y, Fong C, Edmonds J. Fracture site-specific deficits in bone size and volumetric density in men hip fractures. J Bone Miner Res 2001; 16: 120-127.
Heidenreich A, Hofmann R, Engelmann UH. The use of bisphosphonate for the palliative treatment of pain bone metastasis due to hormone refractory prostate cancer. J Urol 2001, 165: 136-140.
Fox KM, Cummings SR, Williams E, et al. Femoral neck and intertrochanteric fractures have different risk factors: a prospective study. Osteoporosis Int 2000; 11: 1.018-1.023.
Seeman E, Duan Y, Fong C, Edmonds J. Fracture site-specific deficits in bone size and volumetric density in men hip fractures. J Bone Miner Res 2001; 16: 120-127.
Heidenreich A, Hofmann R, Engelmann UH. The use of bisphosphonate for the palliative treatment of pain bone metastasis due to hormone refractory prostate cancer. J Urol 2001; 165: 136-140.
Lindsay R, Silvermnan SL, Cooper C, et al. Risk of new vertebral fracture in the year following a fracture. JAMA 2001; 285: 320-323.
Lane JM, Khan SN, O´Connor WJ, et al. Bisphosphonate therapy in fibrous dysplasia. Clin Orthop 2001; 382: 6-12.
Bekker PJ, Holloway D, Nakanishi A, et al. The effect of a single dose of osteoprotegerin in postmenopausal women. J Bone Miner Res 2001; 16: 348-360.
Frost ML, Blake GM, Fogelman I. Quantitative ultrasound and bone mineral density are equally strongly associated with risk factors for osteoporosis. J Bone Miner Res 2001; 16: 406-416.
Martini G, Valenti R, Giovani S, et al. Influence of insulinlike growth factor-1 and leption on bone mass in healthy postmenopausal women. Bone 2001; 28: 115-117.
Heiskanen JT, Kroger H, Paakkonen M, et al. Bone mineral metabolism after total gastrectomy. Bone 2001; 28: 123-127.
Karlsson MK, Magnusson H, Karlsson C, Seeman E. The duration of exercise an a regulator of bone mass. Bone 2001; 28: 128-132.
Mühlbauer, Li F, Lozano A, et al. Some vegetable (commonly consumed by humans) efficiently modulate bone metabolism. J Musculoeskel Neuron Interact 2000; 1: 137-140.
Phillipov G, Seaborn CJ, Phillips PJ. Reproducibility of DXA: Potencial impact on serial measurement and misclassification of osteoporosis. Osteoporosis Int 2001; 12: 49-54.
Wilkinson JM, Stockley I, Peel NFA, et al. Effect of pamidronate in preventing local bone loss after total hip arthoplasty: a randomized, double-blind, controlled trial. J Bone Miner Res 2001; 16: 565-571.
Van Staa TP, Leufkens HGM , Cooper C. Use of inhaled corticosteroids and risk of fractures. J Bone Miner Res 2001; 16: 581-588.
Tellier V, De Maeseneer J, De Prints L, et al. Intensive and prolongued health promotion strategy may increase awareness of osteoporosis among postmenopausal women. Osteoporosis Int 2001; 12: 131-135.
Cranney A, Guynatt G, Krolicki N, et al. A meta-analysis of etidronatefor the treatment of postmenopausal osteoporosis. Osteoporosis Int 2001; 12: 140-151.
Zivin JR, Gooley T, Zager RA, Ryan MJ. Hypocalcemia: a pervasive metabolic abnormality in the cdritically ill. Am J Kidney Dis 2001; 37: 689-698.
Hakkinen A, Sokka T, Kotaniemi A, Hannonen P. A randomized twoyear study of the effects of dynamic strenght training on muscle strenght, disease activity functional capacity and bone mineral density in early rheumathoidarthritis. Artrtis Rheum 2001; 44: 515-522.